Structural Proteomics: Detection of Neurodegenerative Protein Modifications

Area of Science:

• Neuroscience
• Biochemistry
• Biomarker Discovery

Background:

• Neurodegenerative disorders remain difficult to detect promptly due to brain complexity.
• There is a critical need for precise, specific, and repeatable clinical biomarkers for these conditions.

Purpose of the Study:

• To review recent advancements in neuroproteomics.
• To analyze current and future strategies for identifying biomarkers for neurodegenerative diseases.

Main Methods:

• Utilizing advanced Mass Spectrometry (MS) based proteomic techniques.
• Exploring novel methods like cross-linking mass spectrometry, hydrogen-deuterium exchange mass spectrometry, and protein footprinting.

Main Results:

• Mass Spectrometry (MS) proteomics accelerates biomarker discovery for diagnosis and prognosis.
• Novel proteomic techniques enable the detection of differentially expressed proteins in specific diseases.

Conclusions:

• Further research is essential to fully understand the brain and its disorders.
• Identifying reliable prognostic and diagnostic biomarkers is key to potentially enhancing brain function or curing diseases.